Life Sciences

Life Sciences

Umbrex is pleased to welcome David Summa with Business Model Innovation.  Dave has 10 years in management at Fortune 100 companies; 10 years as CEO of Silicon Valley startups; over 60 years of experience on Board of Directors; and was a partner at McKinsey where he ran the Global Innovation Practice.  Today, Dave is a partner in Business Model Innovation LLC where he advises CEOs, does consulting projects and takes on acting management assignments.  He has operating and consulting experience in life sciences (Rx development, devices, instrumentation, ag); developing countries (Gates Foundation for 5 projects all involving sub-Saharan Africa); and clean tech (electrochromic windows, biofuels and microbial-derived chemicals).  Dave is an astrophotographer and swimmer.  He works with clients anywhere and prefers to work on-site.

Umbrex is pleased to welcome Brenna Rauw with Vulpine Strategies.  Brendan Rauw was a project leader at BCG in the private equity and healthcare practices, and spent ten years after BCG leading technology commercialization for universities.  Brendan has particular expertise in intellectual property, licensing, and entrepreneurship in the life sciences.

Brendan lives in Portland, OR, advising private equity investors and pre-revenue life science companies across the country on strategy, partnering, and market assessment.  Brendan is particularly interested in healthcare and life sciences projects relating to market analysis and due diligence.

Umbrex is pleased to welcome Rodolphe Lebrun with LDP Partner.  Rodolphe Lebrun is an advisor and interim executive for biotech, medtech and biopharma. He spent 5 years at McKinsey focusing on Life Sciences and led commercial excellence at AbbVie Belgium for 2 years. Prior to McKinsey, he was a R&D project manager in aerospace within the Safran group. Rodolphe supports Life Sciences companies across their lifecycle: raising venture capital as interim CEO for startups, reviewing go-to-market strategies in scale-ups and improving biologics manufacturing in Big Pharma. He lives in Belgium and serves clients mostly in Europe.

Umbrex is pleased to welcome Tushar Srivastava. Tushar is an independent strategy consultant who started his consulting career at McKinsey where he spent more than 3.5 years working as a generalist, eventually developing a spike in healthcare and life sciences. He has spent more than 3 years working as an Independent with multiple projects in pharma, life sciences, medical technology and healthcare.

Functionally, he is comfortable working on strategy initiatives across R&D, marketing, operations, technology, and pre-sales. He is open to collaborating on projects and supporting (research/analytics) clients without a restriction on geography, he has worked on projects in North America, Europe and APAC.